Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Steen Bærentzen"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Acute mixed cellular and antibody-mediated rejection (MR) has an estimated prevalence of 7.8%. However, knowledge of MR immune pathogenesis in cardiac graft rejection remains sparse. We report a case of acute MR in a heart transplant patient with a m
Externí odkaz:
https://doaj.org/article/47e51177c3014d9f98b7458b79f00b4f
Autor:
Ninna Aggerholm-Pedersen, Katja Maretty-Kongstad, Johnny Keller, Steen Baerentzen, Akmal Safwat
Publikováno v:
Translational Oncology, Vol 9, Iss 4, Pp 322-328 (2016)
OBJECTIVE: Certain biomarkers such as the C-reactive protein, serum albumin, and the neutrophils to lymphocyte ratio are of prognostic significance regarding survival in different types of cancers. Data from sarcoma patients are sparse and mainly der
Externí odkaz:
https://doaj.org/article/92b5469c361d41e39a804fc7bbf4e747
Autor:
Anne Soejbjerg, Suzan Dyve, Steen Baerentzen, Georg Thorsell, Per L Poulsen, Jens O L Jorgensen, Ulla Kampmann
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Pp 1-4 (2016)
Solitary sellar plasmacytomas are exceedingly rare and difficult to distinguish from other pituitary tumors. We report a case of a 62-year-old woman presenting with blurred vision of the right eye and tenderness of the right temporal region, which wa
Externí odkaz:
https://doaj.org/article/3ae08718c8824c83a110702ea73cd1f8
Autor:
Mette Abildgaard Pedersen, Thomas Baad-Hansen, Lars C. Gormsen, Steen Bærentzen, Birgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen, Mikkel Holm Vendelbo
Publikováno v:
Cancers
Volume 15
Issue 3
Pages: 816
Pedersen, M A, Baad-Hansen, T, Gormsen, L C, Bærentzen, S, Sandfeld-Paulsen, B, Aggerholm-Pedersen, N & Vendelbo, M H 2023, ' Inclusion of Metabolic Tumor Volume in Prognostic Models of Bone and Soft Tissue Sarcoma Increases the Prognostic Value ', Cancers, vol. 15, no. 3, 816 . https://doi.org/10.3390/cancers15030816
Volume 15
Issue 3
Pages: 816
Pedersen, M A, Baad-Hansen, T, Gormsen, L C, Bærentzen, S, Sandfeld-Paulsen, B, Aggerholm-Pedersen, N & Vendelbo, M H 2023, ' Inclusion of Metabolic Tumor Volume in Prognostic Models of Bone and Soft Tissue Sarcoma Increases the Prognostic Value ', Cancers, vol. 15, no. 3, 816 . https://doi.org/10.3390/cancers15030816
Sarcomas are rare and have a high mortality rate. Further prognostic classification, with readily available parameters, is warranted, and several studies have examined circulating biomarkers and PET parameters separately. This single-site, retrospect
Autor:
Ninna Aggerholm-Pedersen, Akmal Safwat, Steen Bærentzen, Marianne Nordsmark, Ole Steen Nielsen, Jan Alsner, Brita S. Sørensen
Publikováno v:
Translational Oncology, Vol 7, Iss 6, Pp 687-693 (2014)
Objective: Reverse transcription quantitative real-time polymerase chain reaction is efficient for quantification of gene expression, but the choice of reference genes is of paramount importance as it is essential for correct interpretation of data.
Externí odkaz:
https://doaj.org/article/8eb1a9bcb36145b3a6aa665722683312
Autor:
Tor Skibsted Clemmensen, Henning Mølgaard, Niels Frost Andersen, Steen Baerentzen, Steen Hvitfeldt Poulsen
Publikováno v:
Case Reports in Cardiology, Vol 2016 (2016)
Patients with cardiac amyloidosis are at increased AV-block and syncope risk. Therefore, a prophylactic pacemaker is often implanted. However, this case illustrates that other mechanisms should be ruled out prior to pacemaker implantation. The patien
Externí odkaz:
https://doaj.org/article/6a6c7d93636c4149bb7eeb3049084f1f
Publikováno v:
Journal of Cancer Science and Clinical Therapeutics.
Autor:
Bjarne Hauge Hansen, Akmal Safwat, Peter Holmberg Jørgensen, Katja Maretty-Nielsen, Thomas Baad-Hansen, Johnny Keller, Ninna Aggerholm-Pedersen, Steen Baerentzen
Publikováno v:
Orthopedic Research and Reviews
Aggerholm-Pedersen, N, Maretty-Nielsen, K, Baerentzen, S, Jorgensen, P H, Hansen, B H, Baad-Hansen, T, Keller, J & Safwat, A 2019, ' Chondrosarcoma : the impact of comorbidity-30 years of experience from a population-based database including 199 consecutive chondrosarcoma patients ', Orthopedic research and reviews, vol. 11, pp. 109-116 . https://doi.org/10.2147/ORR.S205953
Aggerholm-Pedersen, N, Maretty-Nielsen, K, Baerentzen, S, Jorgensen, P H, Hansen, B H, Baad-Hansen, T, Keller, J & Safwat, A 2019, ' Chondrosarcoma : the impact of comorbidity-30 years of experience from a population-based database including 199 consecutive chondrosarcoma patients ', Orthopedic research and reviews, vol. 11, pp. 109-116 . https://doi.org/10.2147/ORR.S205953
Background: Adjustment for comorbidity when investigating potential prognostic factors, especially in elderly cancer patients, is imperative. Patients diagnosed with chondrosarcoma are elderly and more comorbidity is expected for these patients. Demo
Autor:
Ninna Aggerholm-Pedersen, Katja Maretty-Nielsen, Johnny Keller, Steen Baerentzen, Akmal Safwat
Publikováno v:
Sarcoma, Vol 2014 (2014)
Background. Comorbidity is an important prognostic factor for survival in different cancers; however, neither the prevalence nor the impact of comorbidity has been investigated in bone sarcoma. Methods. All adult bone sarcoma patients from western De
Externí odkaz:
https://doaj.org/article/536701010d0e446394dad25022403e9d
Publikováno v:
Ugeskrift for laeger. 182(50)